Your browser doesn't support javascript.
loading
Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder.
Hua, Daniel Ying-Heng; Hindocha, Chandni; Baio, Gianluca; Lees, Rachel; Shaban, Natacha; Morgan, Celia J; Mofeez, Ali; Curran, H Valerie; Freeman, Tom P.
Afiliação
  • Hua DY; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
  • Hindocha C; Clinical Psychopharmacology Unit, UCL, London, UK.
  • Baio G; University College London, London, UK.
  • Lees R; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
  • Shaban N; University of Oxford, Oxford, UK.
  • Morgan CJ; Washington Singer Labs, University of Exeter, Exeter, UK.
  • Mofeez A; Pain Management Centre, National Hospital for Neurology and Neurosurgery, UCLH, London, UK.
  • Curran HV; Clinical Psychopharmacology Unit, UCL, London, UK.
  • Freeman TP; Addiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK. t.p.freeman@bath.ac.uk.
Transl Psychiatry ; 13(1): 131, 2023 04 21.
Article em En | MEDLINE | ID: mdl-37085531

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Cannabis / Abuso de Maconha / Alucinógenos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Canabidiol / Cannabis / Abuso de Maconha / Alucinógenos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article